The role of TRAIL death receptors in the treatment of hematological malignancies

Leukemia & Lymphoma
Elizabeth S HensonSpencer B Gibson

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising new treatment for the hematological malignancies. TRAIL induces apoptosis by binding to its two death receptors DR4 (TRAIL-R1) and DR5 (TRAIL-R2). The extent of apoptosis by TRAIL is tightly regulated by the expression of these receptors and by downstream signaling. Chemotherapeutic agents increase the expressions of DR4 and DR5 on tumor cells through the activation of various transcription factors and there is enhanced killing on combining these agents with TRAIL. In this review, we will discuss the mechanism of TRAIL death receptor-induced apoptosis and the regulation of DR4 and DR5 expression. In particular, we will focus on the regulation of TRAIL death receptor signaling in hematological malignancies and the mechanisms responsible for the sensitization of leukemia and lymphoma cells to TRAIL-induced apoptosis by chemotherapy. Finally, we shall review the clinical data regarding the use of recombinant TRAIL and activating monoclonal antibodies against the TRAIL death receptors in the hematological malignancies.

References

Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Apr 21, 1999·Current Opinion in Cell Biology·A Ashkenazi, V M Dixit
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
May 31, 2001·Journal of Cellular Physiology·B GuanS Y Sun
Sep 28, 2002·Blood·Irene M PedersenJohn C Reed
Nov 25, 2003·Oncogene·Shulin Wang, Wafik S El-Deiry
Mar 23, 2004·Current Cancer Drug Targets·Albert F KaboreSpencer B Gibson
Apr 28, 2004·Vitamins and Hormones·Nina-Beate Liabakk, Terje Espevik
Apr 28, 2004·Vitamins and Hormones·Bharat B AggarwalYasunari Takada
Jul 15, 2004·Current Opinion in Pharmacology·Sean K Kelley, Avi Ashkenazi
Sep 17, 2004·Leukemia & Lymphoma·James B JohnstonSpencer B Gibson
Sep 25, 2004·Journal of Cellular Physiology·Roberta Di Pietro, Giorgio Zauli
Oct 27, 2004·Cancer Science·Hideo YagitaKo Okumura
Nov 20, 2004·Cancer Gene Therapy·Lidong Zhang, Bingliang Fang
Mar 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rebecca L VanoostenThomas S Griffith
Apr 30, 2005·Cell Death and Differentiation·M MacFarlaneG M Cohen
Jun 7, 2005·Genes & Development·Céline Gélinas, Eileen White
Jun 21, 2005·Molecular and Cellular Biology·Shashirekha ShettySpencer B Gibson
Oct 15, 2005·Leukemia·S H Kaufmann, D P Steensma
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Albert F KaboreSpencer B Gibson
Jun 6, 2006·Cytokine & Growth Factor Reviews·Giorgio Zauli, Paola Secchiero
Aug 4, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E W DuikerE G E de Vries
Sep 19, 2006·Molecular and Cellular Biology·Delphine MérinoOlivier Micheau
Oct 14, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·J R Fisher, B E Ostrov

❮ Previous
Next ❯

Citations

Jul 6, 2010·Cancer Immunology, Immunotherapy : CII·Jessica C ShandCraig A Mullen
Mar 10, 2010·Molecules and Cells·Mary K WilsonMark S Schlissel
Mar 30, 2010·Apoptosis : an International Journal on Programmed Cell Death·Changbao ChenYingyu Chen
Sep 23, 2011·Cellular and Molecular Neurobiology·Yanli NiuJinbo Deng
Apr 19, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Annegret HofscheierLeticia Quintanilla-Martinez
Sep 24, 2013·Apoptosis : an International Journal on Programmed Cell Death·Ju-Yoon YoonSpencer B Gibson
Jul 26, 2012·International Journal of Cell Biology·Versha Banerji, Spencer B Gibson
Jul 14, 2011·Leukemia & Lymphoma·Ganchimeg IshdorjSpencer B Gibson
Apr 14, 2009·Blood Reviews·Antònia Obrador-HeviaJosé Rodríguez
Feb 19, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rama D MittalPriyanka Srivastava
Feb 5, 2014·Biochemical and Biophysical Research Communications·Dae-Hee LeeTae-Hwa Lee
Sep 10, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·D D CuiC Yi
Aug 17, 2010·Journal of Leukocyte Biology·Andre Ortlieb Guerreiro-CacaisVictor Levitsky
Apr 5, 2019·Journal of Medical Virology·Shahira Amin ZayedAmira Ramadan Korany Harb
Nov 13, 2008·Acta Medica (Hradec Králové)·Martina RezácováDoris Vokurková
Apr 26, 2017·Oncology Reports·Mohammed I Y ElmallahMohamed S Abdelfattah

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Neuropathology and Applied Neurobiology
J M A KuijlenW Helfrich
Apoptosis : an International Journal on Programmed Cell Death
S BouralexisA Evdokiou
© 2021 Meta ULC. All rights reserved